# Prevention of Microvascular Complications in Prediabetes e-PREDICE Study

> **NCT03222765** · NA · UNKNOWN · sponsor: **Evidem Consultores SL** · enrollment: 1000 (estimated)

## Conditions studied

- PreDiabetes

## Interventions

- **DRUG:** Placebo, metformin, linagliptin, linagliptin + metformin

## Key facts

- **NCT ID:** NCT03222765
- **Lead sponsor:** Evidem Consultores SL
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-03-15
- **Primary completion:** 2018-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2017-07-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03222765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03222765, "Prevention of Microvascular Complications in Prediabetes e-PREDICE Study". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03222765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*